ARCT - Arcturus Therapeutics Holdings Inc. | Scanr.ai
ARCT
Arcturus Therapeutics Holdings Inc.
Manufacturing
|
Pharmaceutical Products
|
XNAS
5.75
-0.01
-0.17%
Jul 28, 3:59 PM EDT
Enlarge chart
Fullscreen chart
O 5.78H 5.7824L 5.57C 5.75Vol 347.91K
Jul 28, 2026
Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious,and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNar-CF program for cystic fibrosis lung disease. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines.
